Literature DB >> 1897264

A comparison of Chinese traditional and Western medical approaches for the treatment of mild hypertension.

N D Wong1, S Ming, H Y Zhou, H R Black.   

Abstract

We compared the efficacy of Chinese traditional treatment for mild hypertension with that of a standard Western medical regimen in a group of 50 well-matched patients (24 allocated to Western medicine and 26 to Chinese traditional medicine) with mild hypertension (diastolic blood pressure 90-104 mmHg). Those receiving Western therapy were treated in a stepped-care fashion with dihydrochlorothiazide and atenolol. Those in the Chinese traditional therapy group received one of two mixtures of nine herbs and other ingredients, depending on symptoms at initial evaluation. Blood pressure dropped significantly in both groups after only a few days on therapy. After 19 days on treatment, the group receiving Western therapy had a fall in blood pressure from 168.2/96.3 mmHg to 137.3/76.7 mmHg (p less than 0.01), while those on Chinese traditional therapy fell from 168.2/95.9 mmHg to 146.4/80.5 mmHg (p less than 0.01). The fall in blood pressure was significantly greater, however, in those given Western therapy. The relief of existing symptoms or development of possible drug side effects was similar in both groups, except for nocturia, occurring more often in the group treated with Western therapy. We conclude that Western therapy is more effective in reducing blood pressure as compared with Chinese traditional therapy, but effective control of blood pressure in mild hypertensives is possible with either form of treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897264      PMCID: PMC2589443     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  2 in total

1.  Shear bond strengths to dentin: effects of surface treatments, depth and position.

Authors:  L Tao; D H Pashley
Journal:  Dent Mater       Date:  1988-12       Impact factor: 5.304

Review 2.  Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study Group.

Authors:  W B Kannel; J T Doyle; A M Ostfeld; C D Jenkins; L Kuller; R N Podell; J Stamler
Journal:  Circulation       Date:  1984-07       Impact factor: 29.690

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.